ACCELStars

Sleep is a highly sensitive digital biomarker of the brain. We believe that measuring sleep with high precision will lead to a better understanding of the pathology of brain and mental illnesses. For example, psychiatric disorders such as depression, bipolar disorder, and schizophrenia; developmental disorders such as attention-deficit/hyperactivity disorder and autism spectrum disorder; and central neurodegenerative disorders such as Parkinson's disease and Alzheimer's disease occur together in many patients with sleep disorders. Our founder, Ueda, is a professor at the University of Tokyo's Graduate School of Medicine. He specializes in sleep and circadian rhythms and is a world-renowned scientist in this area. CEO Miyahara also has many years of business development and company management experience in the digital health field. Also, Iwasa, an outside director, is a very well-known executive in the Japanese hardware industry. Executive Director Ogata is the founder of a well-known Japanese AI venture that has been funded by Google and is an expert in machine learning. Our strength is our service using the world's most accurate sleep measurement technology. ACCEL, the world's most accurate sleep measurement technology, can detect mid-onset arousal with extremely high accuracy.Fitbit and Apple watch can detect mid-awakening only 50% of the time, but our ACCEL can detect mid-awakening more than 80% of the time.